Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
2,596.0
32.8 (1.28%)

 

  • STI Straits Times Index
    2,596.0
    32.8 (1.28%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,576.4
    19.8 (1.27%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    25,230.7
    -13.4 (-0.05%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,320.7
    1.5 (0.04%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    23,249.6
    405.7 (1.78%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    5,239.2
    5.8 (0.11%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 2,005.1M
  • Value: 1,560.6M
  • Rise: 244
  • Fall: 123
  • Unch: 441

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Jiutian Chemical0.036+0.018
Medtecs Intl1.560+0.150
QT Vascular0.008+0.001
Oceanus^0.008-
ThaiBev0.605+0.005
KLW0.005+0.001
Genting Sing0.720+0.015
SingHaiyi0.069-
Rex Intl0.181-0.001
Sembcorp Marine0.245-0.105

World Indices

World Indices
Name Last Change
Nasdaq 9,757.2 -259.8
HSI 24,246.6 -303.4
HSCEI 9,742.1 -111.1
Jakarta 4,863.1 -41.0
Nikkei 225 22,062.1 -450.0
SSE Comp 2,958.7 -11.9
Shanghai A 3,101.3 -12.4
Shanghai B 211.6 -1.8
KOSPI 2,098.0 -36.7

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

OPKO HEALTH INC OPKO HEALTH INC
Updated on 12 Aug 2020 (End of trading day)
Last (USD): 4.720 Change: -0.250 High: 5.050 Remarks: -
Change (%): -5.03 Low: 4.470
Open 5.000 Yesterday's Close 4.97
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 21,061,880 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -0.47016 Trailing EPS (USD) e -0.29834 NAV (USD) b 2.3713
PE a - Trailing PE f - Price / NAV b 1.9905
Dividend (USD) d - Cash In Hand (USD) g 0.0323 Issued & Paid-up Shares c 669,831,000
Dividend Yield (%) d - Price / Cash In Hand g 146.130 Treasury Shares h 549,907
Market Cap (M) 3,161.602 Enterprise Value (M) 3,471.052
Piotroski F Score 1 Exchange Code OPK Par Value ( $ ) n.a.
52 Weeks Volatility (%) 95.20 Free Float (%) 60.2
Sector & Industry Health Technology - Pharmaceuticals: Major
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 31 Jul 2020.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 09 Aug 2017.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference OPKO HEALTH INC NASDAQ 3,161.602 - - 1.9905 -
Industry Pharmaceuticals: Major NASDAQ 1,689.065 114.250 41.883 2.6400 0.008
Local Peer SANOFI SPON ADR ECH REP 0.5 ORD SHS NASDAQ 130,400.487 40.078 10.616 1.8340 -
Local Peer ROYALTY PHARMA PLC NASDAQ 27,310.505 11.629 11.629 5.2928 -
Local Peer REPLIGEN CORP NASDAQ 7,504.197 350.482 242.548 6.8218 -
Local Peer HUTCHISON CHINA MEDITECH SPON ADS EACH REPR 5 ORD SHS NASDAQ 4,826.225 - - 14.1071 -
Local Peer GRIFOLS SA SPON ADR EA REPR 1 ORD EUR0.10 NASDAQ 4,784.078 6.837 7.772 0.7940 -
Local Peer ALLAKOS INC NASDAQ 4,286.797 - - 9.5901 -
Local Peer LEGEND BIOTECH CORP SPON ADS EACH REP 2 ORD SHS NASDAQ 4,111.987 - - -24.7222 -
Local Peer NEKTAR THERAPEUTICS NASDAQ 3,595.890 - - 2.8624 -
Local Peer REATA PHARMACEUTICALS INC NASDAQ 3,473.026 - - 14.9940 -
Local Peer PRINCIPIA BIOPHARMA INC NASDAQ 2,900.430 - - 8.2530 -
Local Peer TURNING POINT THERAPEUTICS INC NASDAQ 2,608.146 - - 3.6692 -
Local Peer KARUNA THERAPEUTICS INC NASDAQ 2,258.625 - - 6.0748 -
Other Local Peers APELLIS PHARMACEUTICALS INC (NASDAQ), SPRINGWORKS THERAPEUTICS INC (NASDAQ), I MAB SPON ADS EACH REP 2.3 ORD SHS (NASDAQ), Y-MABS THERAPEUTICS INC (NASDAQ), IGM BIOSCIENCES INC (NASDAQ), ZEALAND PHARMA AS SPON ADR EACH REP 1 ORD SHS (NASDAQ), FORMA THERAPEUTICS HLDGS INC (NASDAQ), KINIKSA PHARMACEUTICALS LTD (NASDAQ), AKERO THERAPEUTICS INC (NASDAQ), ODONATE THERAPEUTICS INC (NASDAQ), AKCEA THERAPEUTICS INC (NASDAQ), ARCTURUS THERAPEUTICS HOLDINGS INC (NASDAQ), CONSTELLATION PHARMACEUTICALS INC (NASDAQ), GOSSAMER BIO INC (NASDAQ), PHATHOM PHARMACEUTICALS INC (NASDAQ), QUANTERIX CORPORATION (NASDAQ), ANNEXON INC (NASDAQ), ARCUTIS BIOTHERAPEUTICS INC (NASDAQ), ATHENEX INC (NASDAQ), GENERATION BIO CO (NASDAQ), REPARE THERAPEUTICS INC (NASDAQ), PETIQ INC (NASDAQ), KRYSTAL BIOTECH INC (NASDAQ), PHIBRO ANIMAL HEALTH CORP (NASDAQ), ORIC PHARMACEUTICALS INC (NASDAQ), KEROS THERAPEUTICS INC (NASDAQ), PROVENTION BIO INC (NASDAQ), APPLIED THERAPEUTICS INC (NASDAQ), TRICIDA INC (NASDAQ), NURIX THERAPEUTICS INC (NASDAQ), OYSTER POINT PHARMA INC (NASDAQ), MIRUM PHARMACEUTICALS INC (NASDAQ), G1 THERAPEUTICS IN (NASDAQ), INOZYME PHARMA INC (NASDAQ), APREA THERAPEUTICS INC (NASDAQ), CALLIDITAS THERAPEUTICS AB SPON ADS EACH REP 2 ORD SHS (NASDAQ), RELMADA THERAPEUTICS INC (NASDAQ), SIGA TECHNOLOGIES INC (NASDAQ), TCR2 THERAPEUTICS INC (NASDAQ), FUSION PHARMACEUTICALS INC (NASDAQ), OCULAR THERAPEUTIX INC (NASDAQ), KALA PHARMACEUTICALS INC (NASDAQ), CRINETICS PHARMACEUTICALS INC (NASDAQ), 89BIO INC (NASDAQ), AC IMMUNE SA (NASDAQ), BIOSPECIFICS TECHNOLOGIES CORP (NASDAQ), ORCHARD THERAPEUTICS PLC SPON ADS EACH REPR 1 ORD SHS (NASDAQ), DURECT CORP (NASDAQ), OVID THERAPEUTICS INC (NASDAQ), SATSUMA PHARMACEUTICALS INC (NASDAQ), IMMUNIC INC (NASDAQ), AMRYT PHARMA PLC (NEW) SPON ADS EACH REP 5 ORD SHS (NASDAQ), AMAG PHARMACEUTICS INC (NASDAQ), IMARA INC (NASDAQ), OSMOTICA PHARMACEUTICALS PLC (NASDAQ), BEYONDSPRING INC (NASDAQ), REDHILL BIOPHARMA LTD SPON ADS EA REPR 10 ORD ILS0.00 (NASDAQ), SUTRO BIOPHARMA INC (NASDAQ), IDEAYA BIOSCIENCES INC (NASDAQ), KALEIDO BIOSCIENCES INC (NASDAQ), HOOKIPA PHARMA INC (NASDAQ), SPERO THERAPEUTICS INC (NASDAQ), MENLO THERAPEUTICS INC (NASDAQ), UROVANT SCIENCES LTD (NASDAQ), POLYPID LTD (NASDAQ), KALVISTA PHARMACEUTICALS INC (NASDAQ), EVELO BIOSCIENCES INC (NASDAQ), BIONDVAX PHARMACEUTICALS SPON ADS REP 40 ORD SHS (NASDAQ), LIQUIDIA TECHNOLOGIES INC (NASDAQ), MILESTONE PHARMACEUTICALS INC (NASDAQ), SCPHARMACEUTICALS INC (NASDAQ), AQUESTIVE THERAPEUTICS INC (NASDAQ), FULCRUM THERAPEUTICS INC (NASDAQ), THERATECHNOLOGIES INC (NASDAQ), VERU INC (NASDAQ), LOGICBIO THERAPEUTICS INC (NASDAQ), GALERA THERAPEUTICS INC (NASDAQ), ESSA PHARMA INC (NASDAQ), GAMIDA CELL LTD (NASDAQ), NEUBASE THERAPEUTICS INC (NASDAQ), SOL GEL TECHNOLOGIES LTD (NASDAQ), CYCLERION THERAPEUTICS INC (NASDAQ), TFF PHARMACEUTICALS INC (NASDAQ), AVENUE THERAPEUTICS INC (NASDAQ), LYRA THERAPEUTICS INC (NASDAQ), MUSTANG BIO INC (NASDAQ), HARROW HEALTH INC (NASDAQ), TYME TECHNOLOGIES INC (NASDAQ), VERRICA PHARMACEUTICALS INC (NASDAQ), AYALA PHARMACEUTICALS INC (NASDAQ), PROTARA THERAPEUTICS INC (NASDAQ), XERIS PHARMACEUTICALS INC (NASDAQ), GENPREX INC (NASDAQ), OBSEVA SA (NASDAQ), GRITSTONE ONCOLOGY INC (NASDAQ), ETON PHARMACEUTICALS INC (NASDAQ), EVOLUS INC (NASDAQ), CHECKPOINT THERAPEUTICS INC (NASDAQ), KITOV PHARMA LTD SPON ADS EACH REP 1 ORD SHS (NASDAQ), TREVI THERAPEUTICS INC (NASDAQ), PHASEBIO PHARMACEUTICALS INC (NASDAQ), CORVUS PHARMACEUTICALS INC (NASDAQ), APTORUM GROUP LIMITED (NASDAQ), NOVAN INC (NASDAQ), EYENOVIA INC (NASDAQ), MEDIWOUND LTD (NASDAQ), THE FS ALSEC ALPHASECTOR (NASDAQ), ADDEX THERAPEUTICS LIMITED SPON ADS EACH REP 6 ORD SHS (NASDAQ), CLEARSIDE BIOMEDICAL INC (NASDAQ), EYEPOINT PHARMACEUTICALS INC (NASDAQ), ADAMIS PHARMACEUTICALS CORPORATION (NASDAQ), LANTERN PHARMA INC (NASDAQ), AKARI THERAPEUTICS PLC SPON ADR EACH REPR 100 ORD (NASDAQ), AERPIO PHARMACEUTICALS INC (NASDAQ), ACER THERAPEUTICS INC (NASDAQ), ARIDIS PHARMACEUTICAL INC (NASDAQ), EDESA BIOTECH INC (NASDAQ), MOLECULIN BIOTECH INC (NASDAQ), ONCTERNAL THERAPEUTICS INC (NASDAQ), CITIUS PHARMACEUTICALS INC (NASDAQ), IMMURON LIMITED SPON ADR EACH REPR 40 ORD SHS (NASDAQ), ALLENA PHARMACEUTICALS INC (NASDAQ), AILERON THERAPEUTICS INC (NASDAQ), BAUDAX BIO INC (NASDAQ), PDS BIOTECHNOLOGY CORPORATION (NASDAQ), MANNATECH INC (NASDAQ), HOTH THERAPEUTICS INC (NASDAQ), MILLENDO THERAPEUTICS INC (NASDAQ), PROPHASE LABS INC (NASDAQ), HISTOGEN INC (NASDAQ), DARE BIOSCIENCE INC (NASDAQ), CNS PHARMACEUTICALS INC (NASDAQ), ENTERA BIO LTD (NASDAQ), TITAN PHARMACEUTICAL INC (NASDAQ), SPRING BANK PHARMACEUTICALS INC (NASDAQ), BRICKELL BIOTECH INC (NASDAQ), CHINA SXT PHARMACEUTICALS INC (NASDAQ), ADIAL PHARMACEUTICALS INC (NASDAQ), TELIGENT INC NEW (NASDAQ), NOVUS THERAPEUTICS INC (NASDAQ)
Global Peer JOHNSON & JOHNSON NYSE 394,027.841 26.062 25.948 6.2566 2.505
Global Peer PFIZER INC NYSE 212,995.210 13.090 15.031 3.3107 3.793
Global Peer NOVARTIS AG ADR-EACH REPR 1 CHF0.5(REGD) NYSE 209,527.406 29.728 29.028 3.8937 -
Global Peer MERCK & CO INC NYSE 209,117.563 21.245 19.956 7.5652 2.744
Global Peer ABBVIE INC NYSE 168,558.913 21.494 24.422 11.4604 3.852
Global Peer ASTRAZENECA SPON ADR EACH REP 0.50 ORD SHS NYSE 148,917.534 111.089 69.177 12.1694 -
Global Peer ELI LILLY AND COMPANY NYSE 145,909.498 31.460 25.971 35.6492 1.693
Global Peer BRISTOL-MYERS SQUIBB CO NYSE 143,440.105 41.710 - 2.9217 2.609
Global Peer NOVO NORDISK A/S ADR-EACH CNV INTO 1 CLASS B DKK1 NYSE 121,604.650 20.826 19.826 13.4373 -
Global Peer GLAXOSMITHKLINE ADR EACH CNV INTO 2 ORD GBP0.25 NYSE 105,765.527 17.848 16.543 6.2972 -
Other Global Peers TAKEDA PHARMACEUTICAL CO LTD SPON ADS EACH REP 0.5 ORD SHS (NYSE), WUXI APPTEC (HKEx), HANSOH PHARMA (HKEx), INNOVENT BIO (HKEx), CANSINOBIO-B (HKEx), SINOPHARM (HKEx), JUNSHI BIO (HKEx), SH PHARMA (HKEx), BAIYUNSHAN PH (HKEx), HENLIUS-B (HKEx), CHINARES PHARMA (HKEx), BIOHAVEN PHARMACEUTICAL HLDG CO LTD (NYSE), CHINAGRANDPHARM (HKEx), HEPALINK (HKEx), ADC THERAPEUTICS SA (NYSE), HYGEIA HEALTH (HKEx), CMS (HKEx), AKESO-B (HKEx), OCUMENSION-B (HKEx), TRAD CHI MED (HKEx), INNOCARE-B (HKEx), SSY GROUP (HKEx), UNITED LAB (HKEx), CSTONE PHARMA-B (HKEx), ZYMEWORKS INC (NYSE), Kimia Farma Tbk. (IDX), AMNEAL PHARMACEUTICALS INC (NYSE), CKLIFE SCIENCES (HKEx), TONGRENTANGCM (HKEx), HUA MEDICINE-B (HKEx), IMMUNOTECH-B (HKEx), IGBB (Bursa), SHINEWAY PHARM (HKEx), NAVIDEA BIOPHARMACEUTICALS INC (NYSE American), TOT BIOPHARM-B (HKEx), FUSEN PHARM (HKEx), BSTEAD (Bursa), AFT PHARMACEUTICALS LTD (ASX), PHARMA (Bursa), STARPHARMA HOLDINGS LIMITED (ASX), PYC THERAPEUTICS LIMITED (ASX), LANNETT CO INC (NYSE), CH BIOTECH SER (HKEx), ZHONGZHIPHARM (HKEx), BIOMX INC (NYSE American), DAWNRAYS PHARMA (HKEx), RECCE PHARMACEUTICALS LTD (ASX), IX Biopharma (SGX), Hyphens Pharma (SGX), Phapros Tbk. (IDX), KOTRA (Bursa), Merck Tbk. (IDX), NEW RAY MEDIC (HKEx), IP (SET), NOVA (Bursa), PAK FAH YEOW (HKEx), PALLA PHARMA LTD (ASX), RACE ONCOLOGY LTD (ASX), BIOHLDG (Bursa), NC HEALTHCARE (HKEx), ONCOSIL MEDICAL LIMITED (ASX), CHARMACY PHAR (HKEx), IMMURON LIMITED (ASX), NEP INTERLONG (HKEx), NOXOPHARM LTD (ASX), AGEX THERAPEUTICS INC (NYSE American), WAI YUEN TONG (HKEx), TBG DIAGNOSTICS LTD (ASX), ANNOVIS BIO INC (NYSE American), INVION LTD (ASX), SANAI HEALTH GP (HKEx), JCT (SET), PURAPHARM (HKEx), EXTRAWELL PHAR (HKEx), PHARMAXIS (ASX), MEDLAB CLINICAL LIMITED (ASX), TIMBER PHARMACEUTICALS INC (NYSE American), SUNZEN (Bursa), PASHUN INT'L (HKEx), ACRUX (ASX), EXOPHARM LTD (ASX), SINOLIFE UTD (HKEx), TALI DIGITAL LIMITED (ASX), CRESO PHARMA LTD (ASX), CELLMID LIMITED (ASX), SUDA PHARMACEUTICALS LTD (ASX), Merck Sharp Dohme Pharma Tbk. (IDX), Pharmesis Intl (SGX), FIJI KAVA LTD (ASX), FARMAFORCE LTD (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --0.935
-16.53 %
10 Days --1.190
-20.14 %
20 Days -+0.690
+17.12 %
Medium Term Return 3 Months -+2.160
+84.38 %
6 Months -+3.150
+200.64 %
1 Year -+2.820
+148.42 %
Long Term Return 2 Years --0.770
-14.03 %
3 Years --1.160
-19.73 %
Annualised Return Annualised --
-7.06 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 1.117 - 6.470 Change From 1 Year Low +3.603 % Change From 1 Year Low (%) +322.52
Change From 1 Year High -1.750 % Change From 1 Year High (%) -27.05
2 Years Range 1.117 - 6.470 Change From 2 Years Low +3.603 % Change From 2 Years Low (%) +322.52
Change From 2 Years High -1.750 % Change From 2 Years High (%) -27.05
5 Years Range 1.117 - 12.150 Change From 5 Years Low +3.603 % Change From 5 Years Low (%) +322.52
Change From 5 Years High -7.430 % Change From 5 Years High (%) -61.15
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

OPKO Health, Inc. engages in the provision of healthcare services. It operates through the following segments: Diagnostics, Pharmaceuticals, and Corporate. The Diagnostics segment include clinical laboratory operations of BioReference, as well as point-of-care operations. The Pharmaceuticals segment includes comprises pharmaceutical operations in Chile, Mexico, Ireland, Israel, and Spain and pharmaceutical research and development operations. The company was founded in October 1991 and is headquartered in Miami, FL.

Historical Price Data

Date Open High Low Close Volume VWAP
12 Aug 2020 5.000 5.050 4.470 4.720 21,061,880 -
11 Aug 2020 5.380 5.380 4.950 4.970 18,519,160 -
10 Aug 2020 5.670 5.695 5.390 5.460 9,513,255 -
07 Aug 2020 5.650 5.760 5.510 5.630 9,639,193 -
06 Aug 2020 5.470 5.880 5.450 5.655 17,061,380 -
05 Aug 2020 5.390 5.496 5.310 5.450 12,388,630 -
04 Aug 2020 5.356 5.437 5.220 5.360 12,211,390 -
03 Aug 2020 5.280 5.500 5.200 5.350 14,990,350 -
31 Jul 2020 5.620 5.860 4.850 5.150 35,658,130 -
30 Jul 2020 5.720 6.020 5.660 5.910 20,337,740 -
29 Jul 2020 5.580 5.900 5.445 5.790 22,319,280 -
28 Jul 2020 5.806 5.960 5.560 5.580 18,888,200 -
27 Jul 2020 5.360 5.970 5.330 5.850 30,298,210 -
24 Jul 2020 5.460 5.530 5.165 5.300 19,782,510 -
23 Jul 2020 5.520 5.900 5.440 5.600 24,368,580 -
22 Jul 2020 5.700 5.700 5.350 5.560 29,084,550 -
21 Jul 2020 5.710 6.470 5.300 5.955 115,173,400 -
20 Jul 2020 4.920 5.090 4.700 4.940 37,158,250 -
17 Jul 2020 4.030 4.830 4.020 4.600 29,020,000 -
16 Jul 2020 4.024 4.130 3.990 4.030 6,836,708 -
15 Jul 2020 4.150 4.160 3.960 4.075 9,386,126 -
14 Jul 2020 3.910 4.040 3.770 4.040 15,010,820 -
Summary
Current 2 Weeks
(30 Jul 2020 to 12 Aug 2020)
5.720 6.020 4.470 4.720 171,381,108 -
Previous 2 Weeks
(16 Jul 2020 to 29 Jul 2020)
4.024 6.020 3.990 5.790 332,929,688 -
4 Weeks from
(17 Jun 2020 to 15 Jul 2020)
2.500 6.020 2.500 4.075 302,498,113 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.